Lv1
84 积分 2024-04-09 加入
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
23小时前
待确认
PCSK9-targeted therapies: present and future approaches
4天前
已完结
LC-MS/MS Investigation of nitrosamine impurities in certain Sartan group medicinal products available in Istanbul, Türkiye
13天前
已完结
1109 First-in-class oral peptide systemically targeting the IL-23 pathway
26天前
已关闭
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours
30天前
已完结
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
1个月前
已完结
A sonosensitive diphenylalanine-based broad-spectrum antimicrobial peptide
1个月前
已完结
NaV1.8 inhibitor poised to provide opioid-free pain relief
1个月前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
2个月前
已完结
GPCR drug discovery: new agents, targets and indications
4个月前
已完结
皖公网安备34019202002308
